This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (28)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Richard T. Johnson, MD

Arch Neurol. 1972;27(2):97-98.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

TWO ARTICLES in this issue of the ARCHIVES OF NEUROLOGY highlight our dilemma in applying rational therapy for herpes simplex virus encephalitis. Since 1966, when Breeden et al¹ reported apparent improvement of this disease after idoxuridine treatment, we have been presented with numerous reports of the salutory effects of this thymidine analogue on herpetic encephalitis. On the other hand, we have remained largely ignorant of the natural history of the untreated disease. In this issue, Farris and Blaw (p 99) report treatment of a patient with herpetic encephalitis with cytarabine and present cogent arguments for the theoretical superiority of this drug. However, in the report by Johnson and associates (p 103), three patients are included with biopsy proven herpetic encephalitis whose outcome without specific therapy was as good or better than that often reported after "successful" antiviral therapy.

Our dilemma arises from the difficulty in establishing a diagnosis . . . [Full Text PDF of this Article]

Author Affiliations
Department of Neurology The Johns Hopkins Hospital Baltimore 21205

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?